iRadimed
IRMD
35 hedge funds and large institutions have $12.9M invested in iRadimed in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 17 closing their positions.
2.79% less ownership
Funds ownership: 16.75% → 13.97% (-2.8%)
19% less capital invested
Capital invested by funds: $16M → $12.9M (-$3.11M)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
24% less funds holding
Funds holding: 46 → 35 (-11)
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.93M |
| 2 |
ECM
Element Capital Management
New York
|
+$170K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$125K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$92.9K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$76.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.46M |
| 2 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
-$1.03M |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
-$758K |
| 4 |
State Street
Boston,
Massachusetts
|
-$595K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$454K |
IRMD Hedge Fund Activity: Q2 2017 in Review
35 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2017, worth a combined $12.9M — down 19% from $16M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of IRMD and 6 opened new positions — a net loss of 11 holders — while 14 trimmed existing stakes and 11 added.
The largest buyer was Ameriprise, opening a new position worth an estimated $2.93M. The largest seller was BlackRock, cutting an estimated $1.46M.
- 35 institutional investors held iRadimed (IRMD) as of Q2 2017, down from 46 in Q1 2017.
- Funds reported $12.9M of iRadimed stock for Q2 2017, down 19% quarter-over-quarter.
- 6 funds opened new iRadimed positions in Q2 2017 and 17 closed out, a net change of -11 holders.
- The largest iRadimed buyer in Q2 2017 was Ameriprise, an estimated $2.93M added.
- The largest iRadimed seller in Q2 2017 was BlackRock, an estimated $1.46M sold.
Based on aggregated 13F filings for Q2 2017.